FDA Import Refusal 1FX-4198422-0/10002/1 — BOEHRINDER LTD
The FDA refused shipment 1FX-4198422-0/10002/1 from BOEHRINDER LTD (India) on Jul 2, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75
Refusal Details
- Date
- Jul 2, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75